Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The "2nd Annual Cell Therapy Bioprocessing Conference" conference has been added to ResearchAndMarkets.com's offering.

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. In the conference of 2017, specific risks and benefits were assessed of the cell culture and cell therapy bio-manufacturing for the cure of these diseases.

There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used.

2nd Annual Cell Therapy Bioprocessing Conference will put together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, taking place in Boston-USA on 25th & 26th June 2020.

Key Highlights

Why Attend?

Agenda

Day 1: Thursday June 25th

CELL CULTURE TO CELL THERAPY

Self-regulated bioprocessing through bioreactor system for monitored 3D cell culture09:00 - 09:30

Multi-omics study on CHO cell lines engineering and bioprocessing09:30 - 10:00

Solution provider presentation10:00 - 10:30

Morning refreshment and One on One Networking10:30 - 11:20

CELL THERAPY BIOPROCESSING AND DEVELOPMENT

Next generation engineered T cells for cell therapy11:20 - 11:50 Jan Joseph Melenhorst, Adjunct Associate Professor, Upenn

Automation of cellular therapies: challenges and solutions11:50 - 12:20

Solution provider presentation12:20 - 12:50

Lunch and One on One Networking12:50 - 13:50

Development of Stem Cell Derived Exosomes for Clinical Applications13:50 - 14:20 Ian McNiece, Vice President, Aegle Therapeutics

Bioprocessing of recombinant adenoassociated virus production by fluorescence spectroscopy14:20 - 14:50

Afternoon refreshment and One on One Networking14:50 - 15:20

PROCESS MONITORING & QUALITY CONTROL

Process development of antigen-specific T cells16:10 - 16:40 Patrick J. Hanley, Director of GMP for Immunotherapy, The Children's Research Institute

Establishing iPSC cell banks derived using reagents and workflows optimized for cell therapy manufacturing16:40 - 17:10

Glycolysis restriction through fermentation technology to preserve T-cell functions and checkpoint therapy17:10 - 17:40

Closing remarks by Chairperson17:40 - 17:45

Drinks reception17:45 - 18:45

End of Conference18:45 - 18:45

Day 2: Friday June 26th

Scale up of allogeneic cell therapy manufacturing in single-use bioreactors: Challenges, insights and solutions09:00 - 09:30

Cell therapy: progress in manufacturing and assessments of potency09:30 - 10:00

Solution provider presentation10:00 - 10:30

Morning refreshment and One on One Networking10:30 - 11:20

Panel Discussion: Autologous vs Allogenic11:20 - 11:50

Quality control and effective purification methods for cell therapy product lines11:50 - 12:20

Solution provider presentation12:20 - 12:50

Lunch and One on One Networking12:50 - 13:50

LOGISTICS, REGULATORY & INVESTMENT

Building a leading edge supply chain, while maintaining flexibility13:50 - 14:20 Devyn Smith, Chief Operating Officer, Sigilon Therapeutics

Raw and starting material control for cell-based medicines14:20 - 14:50

FDA guidelines for regulatory issues involved cell therapy manufacturing14:50 - 15:20

Closing remarks by Chairperson15:20 - 15:25

End of Conference15:25 - 15:25

For more information about this conference visit https://www.researchandmarkets.com/r/jhs3n8

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

Link:
2nd Annual Cell Therapy Bioprocessing Conference | Boston, MA, USA - June 25-26, 2020 | Network with Key Professionals Addressing the Strategies of...